Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
Completed
National Institute on Drug Abuse (NIDA)
Phase 2
1997-10-01
The purpose of this study is to empirically test a series of medications to: 1) determine
each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective
dose range for each medication. In this study, baclofen is tested.
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
Completed
University of California, Los Angeles
Phase 2
1997-10-01
The purpose of this study is to empirically test a series of medications to: 1) determine
each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective
dose range for each medication. In this study, baclofen is tested.
Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia
Completed
University of Pittsburgh
N/A
1998-06-01
OBJECTIVES: I. Evaluate the efficacy of L-baclofen in patients with refractory trigeminal
neuralgia.
II. Evaluate the safety and tolerance of L-baclofen in these patients.
A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis
Completed
UCB Pharma
Phase 3
2005-01-01
This was a multicenter, open-label, randomized, crossover trial in subjects with MS who were
already taking a stable dose of baclofen (up to 80 mg/day) for spasticity. The trial was
designed to assess subject preference for Kemstro or conventional baclofen. At Visit 1,
subjects were screened, and if qualified, were randomly assigned to one of two following
treatment sequences: Kemstro/conventional baclofen or conventional baclofen/Kemstro.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
